Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionRegulation of immune cell function and differentiation by the NKG2D receptorAn approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma.An six-amino acid motif in the alpha3 domain of MICA is the cancer therapeutic target to inhibit sheddingCellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G.Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells.NK1.1- CD4+ NKG2D+ T cells suppress DSS-induced colitis in mice through production of TGF-βN-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24.Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expressionExpansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.Regulation of ligands for the NKG2D activating receptor.Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells.The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2DOncogenic stress sensed by the immune system: role of natural killer cell receptorsExpression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells.CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation.NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system.Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status.MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.Activation and self-tolerance of natural killer cells.The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathiesHuman natural killer cells.Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.Substantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1.Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupusNK cells and cancer immunosurveillance.NKG2D ligands in tumor immunity.Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy CellsFighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Human fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells.Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases.Cancer immunoediting of the NK group 2D ligand H60a.The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases.Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphism.
P2860
Q21131219-DD81F661-67EA-4701-812E-CEE62E371D4BQ24635093-97363719-1FB9-4BC3-AE5C-8758771D42E6Q30400692-6893837C-8045-4B63-92C4-4BF188E9E33BQ30489974-7F569AD7-4147-4FBA-869E-FA8A95685D4AQ33410094-5759F59D-94F6-4457-9A2B-A524A37826FAQ33676231-C476C629-8AA3-449B-9A71-412AB15CF40EQ33844629-999B05DB-404F-4DE7-8795-66930B49A451Q33931165-8B1400C2-9B14-48D3-AACA-BEBD0F9829D1Q33999130-D319D5EE-2376-45B1-9AEB-510056232DEAQ34294166-21B7DE89-14D9-4EC5-A0A7-14E35F2423CBQ34321457-6715BAA7-FFBA-48B9-BAA0-026070EE34B4Q34368956-53EAB7D9-FFFC-483F-B134-B1F05FF81A21Q34467682-938DDD6F-50A3-4137-9412-4347617EDBA5Q34473267-289F5801-92D6-40EF-B707-00F5507F5443Q34652549-58F3A6BF-B9CC-4C5E-8A7F-0E46B8E8FE8BQ35055326-0B59E738-D2D7-494E-BAC9-2C8AFC3A2457Q35562281-E371EDFC-097C-4B8B-A0C1-C600A2B1297FQ36060273-99954F4B-B849-406D-9E8A-D920A03779E6Q36446189-6F8E954E-3FF9-4536-855B-3A05B539B426Q36652183-3AC4C39B-5935-4702-BB1B-A0A076B162ECQ36685376-C6C100D8-F614-4B98-824C-CD549C3BF6E2Q36787596-827CE7AF-0078-414E-A03B-A9B36E60D3A1Q36810264-2C428F95-5BF6-4095-A930-17DEA7CF0DA5Q37077413-788FFB2C-B25E-4B28-A7E5-E6F8F00FA090Q37116995-C1D4831A-53BD-4E3B-970D-9709535E6F2DQ37273292-4BB31E99-8113-4D76-B118-AE40CF9D56A2Q37287176-D3EA1CA8-7C5D-4264-AD98-CBEB2ADABF93Q37287179-11EB69F4-9472-486B-A643-2B4959013EF2Q37559284-0DB3E97D-F361-4676-B25D-7D68B61B4309Q37667998-55D770C6-8EED-459C-AC01-4168A3C9EB95Q37714638-9EB3B6BE-4223-47CC-B4C3-508DAF35C9BBQ37876089-3703C38C-0159-4C79-8C92-B43AD1AAF393Q38223419-2F07BDFB-574E-4642-B511-5085A00D327DQ38257969-5788573A-93D8-48B1-B7E6-5A1F80CD21F3Q38546761-CB7C58F9-3ECC-45E9-AAC1-81057ED45A5CQ38685657-6C5E8155-0C16-4E23-8192-931EE0A1231CQ39176227-BD04AA34-C133-4263-BF90-5E40CC861FF9Q39537390-A4B9AFA1-F827-493C-AE52-EBB9873A4D89Q40109211-276C08A7-62EE-4324-A3F1-EFEBFF41DA81Q40399586-845D81A0-3BB5-40B2-B0EB-98FEE3FD9609
P2860
Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
@en
Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
@nl
type
label
Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
@en
Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
@nl
prefLabel
Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
@en
Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
@nl
P2093
P2860
P356
P1433
P1476
Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
@en
P2093
Kimberly Smythe
Thomas Spies
Veronika Groh
Zhenpeng Dai
P2860
P304
P356
10.1038/NI1350
P407
P577
2006-05-28T00:00:00Z